During an assessment under our new approach
We carried out an announced focused assessment of Balance My Hormones Ltd between 25 February to 5 March 2025 following information that we received, to check the systems and processes in place to manage the service.
The provider, Balance My Hormones Limited is registered to provide the regulated activity of treatment of disease, disorder or injury. This is an exclusively online remote consultation service which has a registered office at International House, 24 Holborn Viaduct, London, EC1A 2BN.
The service primarily provides treatment for testosterone replacement therapy (TRT), alongside HRT hormone and adjunctive treatments for associated conditions . Testosterone deficiency means the body is unable to make enough testosterone.
Patients access the providers services via the Balance my Hormones website: www.balancemyhormones.co.uk and have the option to access assessment and possible treatment from there.
Since the previous inspection on 10 July 2023, the service had experienced considerable growth and transitioned into a fully integrated digital healthcare service.The service is supported by both clinical and non-clinical teams led by a registered manager, with an administrative support team assisting patients and facilitating communication between clinicians and patients. Where relevant, further commentary is provided in the quality statements section of this report. The assessment reviewed the key questions for safe and well-led.
The overall rating for this assessment is Good.
SAFE: The service had a good learning culture and patients could raise concerns. Incidents were investigated to understand and mitigate risks. People were protected and kept safe. There were enough staff with the right skills and experience. Managers made sure staff received training and regular appraisals to maintain high-quality care. Staff generally managed medicines well and involved patients in planning any changes. While some elements of clinical governance and oversight were limited, we found no evidence of patient harm. The provider was responsive in making or planning improvements where issues were found.
WELL-LED: Leaders and staff shared a vision and culture based on listening, learning, and trust. Leaders were visible, knowledgeable, and supportive, helping staff develop in their roles. Staff felt supported to give feedback and were treated equally, free from bullying or harassment. They understood their roles and responsibilities. Managers worked to deliver the best possible care and were receptive to new ideas. There was a culture of making improvements alongside staff to share and implement new ideas. Although we observed improvements from previous inspections, some areas of clinical governance where we had indicated the provider should improve and must improve, had recurred. Further work was required to ensure effective governance and management of clinical risks and the quality and safety of patient care, which we have identified as areas for the provider to improve.